CIBERSAM
CIBERSAM CIBERSAM CIBERSAM CIBERSAM
/ Research groups / Research programs
AMPLIAR CIBERSAM

Schizophrenia

Esquizofrenia Schizophrenia is a priority research objective within the CIBERSAM. One of the most serious mental disorders and one that causes a high degree of disability, economic cost, and family suffering. This illness affects approximately 400,000 Spanish people. People suffering from this disorder have a reduction in their life expectancy of nearly 20 years.

CIBERSAM Research in Schizophrenia
The structure of the Centro de Investigación Biomédica en Red de Salud Mental incorporates a broad network of basic and clinical centres in which the national groups with the most schizophrenia research experience participate. Their collaboration is making it possible to provide a multidimensional approach to the complex problems related to the origin, course, and treatment of this disease. The CIBERSAM’s research is enabling remarkable advances in that knowledge and have resulted in important publications in journals with maximum international impact.

The following can be found among the main objectives:
  • Obtaining a broad sample of patients with first psychotic episodes and organising their evolutive study.

  • Studying genetic, neurophysiologic, neuroimaging (structural, neurochemical, and functional), and biochemical variables in the initial phases of psychosis.

  • Study of the neurobiologic (genetic, neuroimaging, and neurophysiologic) bases of the different symptomatologic phenotypes of schizophrenia.

  • Studying the neurobiologic (neuroimaging, neurophysiologic, and cognitive) and clinical response phenotypes prior to different drug treatments.

  • Investigating the efficacy and effectiveness of psychotherapeutic treatments in combination with standard drug treatments in schizophrenia.

  • Studying the repercussions of schizophrenia on health status, psychosocial adjustment, quality of life, individual levels of disability, and patterns of service use on the part of those patients and their influence on comorbidity.




Coordination and member groups

Coordinator: Julio Sanjúan Arias

Groups members:


@ Cibersam
C/Doctor Esquerdo, 46 | 28007 Madrid
Metro Sainz de Baranda
915 570 795 | cibersam@cibersam.es
Legal information | Help | Suggestions | Forum